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Abstract
Background—Determining the costs of healthcare delivery is a key step for providing efficient 
nutrition-based care. This analysis tabulates the costs of delivering home parenteral nutrition 
(HPN) interventions and clinical assessments through encrypted mobile technologies to increase 
patients’ access to healthcare providers, reduce their travel expenses, and allow early detection of 
infection and other complications.
Methods—A traditional cost-accounting method was used to tabulate all expenses related to 
mobile distance HPN clinic appointments, including (1) personnel time of multidisciplinary 
healthcare professionals, (2) supply of HPN intervention materials, and (3) equipment, connection, 
and delivery expenses.
Results—A total of 20 mobile distance clinic appointments were conducted for an average of 56 
minutes each with 45 patients who required HPN infusion care. The initial setup costs included 
mobile tablet devices, 4G data plans, and personnel's time as well as intervention materials. The 
initial costs were on average $916.64 per patient, while the follow-up clinic appointments required 
$361.63 a month, with these costs continuing to decline as the equipment was used by multiple 
patients more frequently over time. Patients reported high levels of satisfaction with cost savings 
in travel expenses and rated the quality of care comparable to traditional in-person examinations.
Conclusion—This study provides important aspects of the initial cost tabulation for visual 
assessment for HPN appointments. These findings will be used to generate a decision algorithm 
for scheduling mobile distance clinic appointments intermittent with in-person visits to determine 
how to lower costs of nutrition assessments. To maximize the cost benefits, clinical trials must 
continue to collect clinical outcomes.
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Introduction
A distance care delivery mode is being investigated to improve how to increase patient 
access to healthcare professionals, detect nutrition and infusion concerns as early as 
possible, and reduce costs and travel to specialist appointments at a distance.1-3 Telehealth 
and telecare are well established for medical consultation, health assessment and monitoring, 
and homecare management at a distance.2,4-6 Mobile health (mHealth) is “the delivery of 
healthcare services via mobile communication devices.”7 mHealth clinics might be most 
advantageous to healthcare providers and their patients requiring home parenteral nutrition 
(HPN) infusion care. mHealth is expected to reduce medical expenditures in HPN infusion 
care,8,9 as patients are able to have communication, consultation, and HPN education in 
their home environments.1-3
mHealth has advantages of encrypted connectivity from multiple and various locations, 
including healthcare professionals’ offices, patients’ homes, and patients’ out-of-town 
vacation locations. mHealth allows patients and family members to interact with healthcare 
providers without travel and receive visual assessments for detecting potential infections, 
nutrition depletion symptoms, and other costly and serious complications of their HPN 
infusion care.3,10,11
National data have also shown that the annual reimbursement for HPN-related health 
services across clinical settings varies and costs approximately $2.3 billion across the United 
States.6,12,13 Based on Medicare and Medicaid reports, reimbursement per patient receiving 
direct care from healthcare professionals annually ranges from $100,000–$250,000, with the 
addition of $75,000–$122,000 to purchase supplies and daily HPN infusion solutions.14,15 
Notably, HPN patients report nonreimbursed healthcare expenditures of $4716 yearly.16 
HPN-related clinic visits include, on average, 36 annually with a variety of health-care 
professionals. In addition, Medicare patients spend a 20% copay for traditional in-person 
clinic visits.12,16,17
With these facts in mind, cost savings are a key issue in the HPN population receiving this 
very expensive area of medical care. mHealth is considered a promising alternative or 
supplement to integrate with traditional in-person clinic visits so that patients can receive 
timely care and diagnoses from healthcare providers at a distance.2,18
Base costs of delivering mHealth HPN interventions by healthcare providers at a distance 
should be identified for further investigation of cost-effectiveness studies. Thus, the purpose 
of this analysis was to determine the costs of implementing mobile distance clinic 
appointments for initial and follow-up appointments when using mobile tablets and 
interactive encrypted videoconferencing. A traditional costing accounting method was used 
to estimate costs.
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Materials and Methods
Mobile Distance Clinic Appointments for HPN Care Delivery
To date, 45 patients requiring long-term HPN infusion care for nonmalignant bowel disease 
participated in this study.11 A total of 20 mobile distance clinic appointments were 
conducted with an average of 56 minutes each. In this study, the modes of delivering a 
mobile distance clinic appointment included (1) mobile tablets with an unlimited data plan, 
(2) video teleconferencing program software, (3) an encryption equipment program for 
Health Insurance Portability and Accountability Act (HIPAA) security, and (4) encrypted 
email accounts and firewalled websites.
During the mobile distance clinic appointments, multiple multidisciplinary professionals 
provided a series of HPN educational interventions regarding (1) problem-solving HPN 
infusion care, (2) infection and depression prevention, (3) fatigue reduction, and (4) peer and 
family support. In addition, patients were individually assessed through a medical history 
report and clinical examination, including visual assessment. Healthcare professionals 
assessed patients’ general health and nutrition status and symptoms of current illness by 
asking structured medical history questions. A subsequent visual physical assessment and 
observations were completed using real-time video and photos of the patient's HPN infusion 
catheter site, abdominal wounds, fistulas, ostomy output container, and abdominal scars.11 
The mobile tablets had an Internet connection to the Oley Foundation for HPN care and the 
National Caregiving Alliance and other family caregiving resources.
Considerations for Implementing a Mobile Tablet Appointment
When considering a mobile device, the multidisciplinary research team, including the 
telehealth center director and a telehealth system coordinator, compared several types of 
mobile tablets and their features, including pixels/resolution, speed, size, and weight, as well 
as cost. In addition, the proposed use with HPN patients was determined. Overall, in this 
study, a mobile tablet was to (1) have a high-resolution screen for increasing visualization of 
the patient's HPN infusion catheter site, abdominal wounds, fistulas, ostomy output 
container, and abdominal scars and (2) be easy to carry and operate. Our selected mobile 
tablet device, the iPad mini, was the only device available at the time that allowed both ease 
of use and the highest resolution on a small screen.
We provided 4G unlimited data plans to standardize the Internet connection using the 
medical center–contract provider. This standardized provision of the 4G data plan has 
several advantages: (1) the medical center 4G data plan costs are less expensive than 
personal plans, (2) our mobile distance clinic appointment can be available anywhere 
regardless of their locations, and (3) the HPN patient will not be restricted to one 
environment with limited connectivity. The 4G data plan has advantages over using home 
Wi-Fi. First, all eligible HPN patients can be included in this study because we did not 
exclude anyone without an Internet connection. Second, study participants were less likely 
to experience technical challenges during videoconferencing through multiple Wi-Fi 
systems with different configuration and firewalls.
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The clinic visit protocol was tested within the week prior to the scheduled visit. A few 
Internet disconnections were resolved with the troubleshooting assistance of a telehealth 
system coordinator. However, this was a very rare event because we provided a 4G 
unlimited data plan. These advantages are critically important for HPN clinical trials for 
increasing the generalizability of our findings in considering persons with lower social 
economic status, computer skills, and technology use.19
Study participants were not required to provide a deposit for obtaining the mobile tablet. 
Instead, they needed to sign a mobile tablet loan and user agreement form, which was 
developed by the telemedicine team on campus and was approved by the university human 
subjects committee and our university legal department. The loan agreement includes 
information about “what is responsible mobile tablet use,” including (1) not storing health 
data related to this study, (2) not storing personal information such as Social Security 
numbers or credit card information, and (3) not obtaining illegal downloaded materials. We 
did not “lock down” the mobile tablet but allowed participants to download software and 
add apps. However, our agreement clearly states the user must be mindful of the Internet 
connection and should “beware of giving personal information out online.” In addition, it 
states that researchers should “follow standard security measures related to the mobile tablet 
using code numbers and no names.”
Health data related to this study or personal information were collected only through an 
encrypted connection. Primary communication with identifiable information occurred 
through 2 encrypted university systems: (1) the telemedicine bridge hosting 
videoconferencing software program for group clinic appointments and (2) a research 
electronic data capture web-based application for data collection/exchange.
Cost Analysis Method
This descriptive cost analysis was conducted using a traditional cost-accounting method that 
tabulates the expenditure data of intervention materials, health professionals’ time, and 
equipment about the mobile tablet and connection software.20,21 Traditional tabulation lists 
the actual cost spending in a spreadsheet. This method has advantages in showing how costs 
are allocated to generate actual production. It is the first necessary process to enhance 
further complex analysis of the specific content of a cost of production report.21 The costs of 
materials and labor were categorized directly into the products of (1) intervention materials 
and (2) implementing the health-care service assessments and interventions through mobile 
tablets and interactive encrypted videoconferencing (see the equation below).
Amortization with multiple cases would occur as equipment has been used by different 
patients over time. In accounting, amortization refers to expensing the acquisition costs 
minus the residual value of equipment and any intangible assets.21,22 Amortization is a 
systematic approach to estimate useful economic life of equipment and to reflect total 
consumption, expiry, obsolescence, or other decline in value as a result of repeated use or 
the passage over time.22
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Data Collection
Costs for the setup stage were based on (1) costs of mobile tablet equipment, (2) connection 
fees for monthly data plans, (3) costs of shipping the tablets, (4) photocopying educational 
handouts, and (5) delivering intervention materials. The clinic appointments and the digital 
version of the intervention materials were provided via mobile tablets with an unlimited 4G 
data plan for a wireless Internet connection. Relevant accessories included a protective 
cover, a screen-protecting film, and device warranty. Few materials were consumed for the 
intervention, including copying, printing, and mailing intervention materials. Encryption 
equipment was used to ensure HIPAA privacy during the mobile distance clinic 
appointments. Supply costs for each specific activity were documented with an expenditure 
log and invoices that a project manager recorded whenever the cost occurred. Costs for the 
implementation stage were based on the time spent by a health counselor, an advanced 
practice psychiatric nurse specialist, and a telemedicine and tele-health system coordinator 
involved in setting up the mobile distance clinic appointments. All personnel costs were 
based on their hourly wages reflecting the hours spent on each mobile distance clinic 
appointment.23-25 The time spent by the interventionists was recorded for each mobile 
distance clinic appointment using time logs (see details in Table 1).
Ethical Considerations
The study was approved by the human subjects committee of our institution. Written 
informed consents were obtained for all study participants.
Results
Total Cost Estimates
The total cost of $916.64 was spent to set up the initial mobile distance clinic appointment, 
providing multidisciplinary HPN infusion care interventions, history taking, and a visual 
assessment for 1 patient (see Figure 1). A total of 60.55% in total costs ($555.01) was spent 
as the fixed cost, which was required regardless of the number of clinic appointments or 
time spent (see details in Table 1).
The total equipment cost of the intervention was $590.62. Most of the cost was spent for 
purchasing a set of devices ($463.95) for one-time purchase of mobile tablets, device 
protection accessories, and videoconferencing software. To ensure HIPAA privacy, 
encryption equipment was purchased ($30,000) specifically for the mobile tablet. Cost 
amortization over multiple cases was applied to determine a per-use equipment charge.22 
Three amortized mobile distance clinic appointments with 1 patient required $380 for 
encryption; thus, per-visit cost for encryption was $126.67. This cost is similar to the 
expense found in a previous study for patients who received 1 in-person specialty care 
visit.16
The supply costs spent were $82.18 for the Internet connection, device maintenance, and 
interventional materials, including (1) $40.81 for the data plan for the Internet connection, 
(2) $4.15 for the monthly fee for the device protection warranty, and (3) $37.22 for 2 hard-
copy intervention booklets requiring paper, printing, and binding. These 2 booklets provided 
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information about the device training guide and HPN infusion care. Delivery fees were, on 
average, $53.84, although the care delivery cost varied depending on delivery regions 
(range, $43.14–$60.38).
Each mobile distance clinic appointment took an average of 56 minutes (approximately 1 
hour). The personnel costs for 2 interventionists and 1 telehealth system coordinator were 
$190 per hour for providing a mobile distance clinic appointment. These costs align with 
reimbursement of actual clinical in-person appointments; one of the interventionists was a 
nurse practitioner who has her own national provider identifier number required for billing 
and insurer reimbursement.
Per-Session Cost
While $916.64 was required for having the initial mobile distance clinic appointment, the 
cost of the follow-up appointment decreased to $361.63 a month. Since the second mobile 
distance clinic appointment, personnel cost per session and device maintenance cost per 
month were required. This cost per session would decrease based on the frequency of 
repeated clinic appointments using the same equipment. As with in-person visits, it is likely 
that these distance appointments will become less lengthy across time, thus decreasing 
personnel costs. Thus, it is estimated that patients requiring HPN infusion care could cost 
$351.63 for 1 mobile distance clinic appointment a month, $270.82 for 2 mobile distance 
clinic appointments a month, $243.88 for 3 mobile distance clinic appointments a month, 
and $230.41 for 4 mobile distance clinic appointments a month (see Figure 2).
Discussion
Overall Patient Rating of Mobile Distance Clinic Appointments
To date in this study, patients have expressed high levels of satisfaction with the 
interventions and care delivery using the mobile tablet. For example, patients stated, “I can 
hear fine,” “It is very convenient,” “The quality of care is similar to an in-person clinic visit 
and these are highly satisfying,” “Nurses are able to understand me well,” and “I can talk 
openly about my personal concerns.” Easier access to healthcare providers was reported as 
beneficial, such as, “I do not have to leave my vacation or college.”
Overall Summary of Analysis of Findings
These cost findings were the foundation and the first step in conducting a full economic 
evaluation of this innovative program of mobile distance clinic appointments. The mobile 
distance clinic appointments, similar to in-person clinics, require a large total initial cost for 
setup and distribution of the device. In the maintenance phase, at least $351.63 is required 
for 1 monthly follow-up mobile distance clinic appointment. However, the costs would 
decrease when patients have more frequent mobile distance clinic appointments. Mobile 
distance clinic appointments could be more cost-effective when patients use mobile tablets 
for long-term care, frequent visits, and supportive peer interactions, while reducing long-
distance trips to see their healthcare providers.6
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Benefits Reducing Patients’ Expenses
Some emergency visits and even hospitalizations could be prevented by early symptom 
detection through mHealth care delivery. Patients with mHealth are able to report their 
symptoms at the onset, while healthcare providers are able to complete visual and auditory 
physical examinations to assess critical patient problems.6,18 For example, 1 patient in our 
current HPN clinical trial used a mobile tablet to send a photograph to his physician, who 
observed the early signs of HPN infusion site infection. Another patient in our HPN clinical 
trial saved a 60-mile round trip by sending photos of her urine 24-hour container for 
measuring her fluid balance. In addition, mHealth and mobile tablets were used in the 
following ways by patients in their HPN infusion care: (1) the mobile tablet camera to better 
see their infusion site during daily HPN care; (2) the mobile tablet web browser to connect 
to the Oley Foundation website; (3) applications (apps) to track supplies, medications, and 
urinary and ostomy fluids; (4) apps to monitor and record weekly laboratory values; (5) 
email to communicate with supportive peers; and (6) media players to watch educational 
videos or movies while waiting to see healthcare providers.
Opportunity Benefit
Saving cost, time, and travel makes mHealth an important care delivery mode.6 The mobile 
distance clinic appointments of this study were able to help patients save on expenses of in-
person clinic visits such as transportation expenses and time conflicts with work schedules. 
It is difficult to quantify the benefit because this study is the only recent research on 
medically related travel expenses and relevant costs for those receiving HPN infusion care in 
the United States.26 This cost-benefit would also be maximized when patients with HPN 
infusion care live in rural areas, at a distance from their usual care providers or HPN care 
specialist, or are disabled and require special transportation services or assistance from 
family or others.2,6 Thus, satisfaction with reducing travel is an extra benefit from mHealth, 
although it does not generate actual revenue.1,13,27 Our analysis provides important cost 
information for clinicians, researchers, and policy makers.
Implications for Research
Compared with standard care, the clinical effectiveness of technological interventions for 
patient instruction, medical and dietary review, and general assessment has been verified, 
but few studies have reported information on costs of care delivery for HPN infusion.3,8,16 
In the published literature on HPN infusion care, there is limited information about cost data 
and economic analyses from the patient's perspective or in the home setting vs acute care 
facilities.3,8,9 Thus, these cost findings of mobile clinic appointments are able to fill gaps in 
the literature, providing basic information on the costs required to implement mobile 
distance clinic appointments with multiple multidisciplinary professionals for patients 
requiring HPN infusion care.
Decisions regarding the selecting of a specific device should be based on thoughtful 
evaluation considering the purposes of the intervention, mobile and computer device 
characteristics, and cost.28 This decision is critically important as equipment costs directly 
influence the clinical efficacy of interventions and cost-effectiveness. Multidisciplinary 
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collaboration with telehealth experts in selecting devices is crucial because mHealth 
technologies are one of the most rapidly changing in the field.29
Our traditional tabulated data provide the costs of the technology, allowing us to conduct 
further complex cost analysis when patient outcome data are completed. Further cost 
analysis will be conducted to investigate the cost-effectiveness of mobile distance clinical 
appointments compared with traditional in-person clinic visits at the end of study. Other cost 
analysis should consider facility costs, any reduction in clinical visits as needed, and cost 
savings from reduced travel.28 Any early identification of infection as well as any other 
significant comorbidity can be analyzed as clinical efficiency. Specifically, a geographic 
information system program30 will be used to generate travel distance data among patients’ 
homes, their primary care providers, and HPN specialists.
Implications for Clinical Practice
This study provides foundational information to formulate a clinical decision tree to decide 
cost-benefit when clinicians schedule cost-effectiveness HPN infusion care planning that 
integrates traditional in-person clinic visits and mobile distance clinic appointments.6,31 The 
mobile distance HPN clinic appointment is beneficial for providing critical and timely 
examination points for visualizing a wound, reviewing an intravenous (IV) or ostomy exit 
site, and assessing HPN technique at home. Also, vital signs and other measurements can be 
taken with peripheral finger sensors and other attachments to mobile tablets, although these 
will add equipment expense.
However, mobile assessment cannot replace in-person visits totally. Some clinical cases 
require traditional in-person clinic visits. For example, some IV sites cannot be fully 
assessed visually, such as infection exudate, swelling, and odors. In addition, laboratory 
abnormalities and prodromal symptoms can be missed, similar to in-person visits. Thus, we 
need to know how to mix 2 modes of care delivery to increase the cost-benefit ratio, 
considering how often and how long patients need to see care providers of HPN infusion 
care.4 Every patient lives in a different geographical region and has different conditions 
requiring clinic visits. Thus, travel costs are an important consideration in determining the 
costs vs benefits.6
A mobile distance clinic appointment consists of a series of HPN-related assessments, 
homecare education, communication, and consultation. Currently, International 
Classification of Diseases, Tenth Revision codes 99213 or 99214 have been used for 
obtaining reimbursement for outpatient clinic visits.32 Both the mobile distance clinic 
appointments and traditional in-person clinic visits require Medicare-certified nurse 
practitioners or medical physicians for reimbursement. This analysis can add economic data 
to the ongoing deliberations about regulations and reimbursement regarding mobile distance 
clinic appointments.
Implications for Healthcare Policy
Emerging mHealth and distance telehealth studies may demonstrate significant cost savings 
for health systems through reduced utilization of emergency departments and inpatient 
services.28 Such data would make it possible for policy makers and insurance payers to 
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support the cost of distance care. As mobile devices become even more ubiquitous and 
standardized, health-care systems such as large medical centers, medical homes, and 
government health services may identify cost-effectiveness, efficacy, and enhanced 
engagement of patients through mHealth use. In addition, the satisfaction of patients and 
family members in combination with ongoing technology development will influence the 
accelerating use of mHealth use.33
Currently, it is early for third-party payers to consider reimbursement for implementation 
costs for an intervention. However, as in-home or clinical telehealth gains reimbursement by 
state and insures due to cost savings, this mHealth approach is likely to follow this recent 
trend in policy.34 Notably, 2013 private-sector investment of $678 million in mHealth 
development indicates the high expectations of use in medical homes, joint practices, and 
outpatient clinics.35 Expenses typically follow after a new approach, concept, or efficacy is 
empirically verified.18,28,29
Study Limitations
Two limitations were identified in this analysis. First, personnel time was based on the 
length of time for each mobile clinic appointment. However, some personnel time was not 
tabulated, such as the time for preparation for the visit or writing up the assessment results 
after visits. Personnel costs are one of the major components of the total cost (20.73%). 
Therefore, this personnel information should be included in future cost calculations.26 
Second, there is the loss of equipment components. All mobile tablets loaned to the patients 
have been returned from our study participants. However, several accessories such as mobile 
tablet chargers and protective covers were not returned and needed to be replaced. Our 
further analysis will tabulate the cost for replacing missing equipment and supplies at the 
end of the clinical trial.
Conclusion
Distance connections use allows healthcare professionals to provide nutrition care 
interventions and assessments of long-distance HPN patients. This new approach using 
mobile distance clinic appointments has saved travel expenses for those who must travel 
long distance. This mobile care delivery aligns with future directions of healthcare and may 
minimize the needs for traditional in-person clinic visits for in-person examinations. Patients 
reported high levels of satisfaction with cost savings in travel expenses and rated the quality 
of care comparable to traditional in-person examinations.
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Clinical Relevancy Statement
Mobile distance clinic appointments can increase access to care and facilitate early 
detection of clinical problems in home parenteral nutrition (HPN) patients. Distance 
connections use allows for improvement in healthcare provision by uniting healthcare 
professionals with patients in overcoming distance barriers and by improving outpatient 
nutrition care, interventions, and assessments of HPN patients. This cost data of mobile 
care delivery system will affect healthcare policy and future nutrition care at home.
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Figure 1. 
Results of cost equation.
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Figure 2. 
Cost tabulation of initial setup and follow-up of mobile distance clinic appointments (unit: 
U.S. dollar).
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Table 1
Cost per Patient for 1 Mobile Distance Home Parenteral Nutrition Clinic Appointment.
Categories Items Detailed Description Cost per Unit Unit Subtotal 
Cost 
per 
Item
Subtotal 
Cost by 
Category
Included 
in Fixed 
Cost
Included in 
Maintenance 
Cost
Equipment cost Mobile tablet $329 1 $329 $590.62 X
Mobile tablet protective covers $27 1 $27 X
Mobile tablet screen protecting 
film
$7.95 1 $7.95 X
Videoconference program software $100 1 $100 X
Encryption equipment Assured HIPAA privacy $126.67 1 $126.67 X
Supply costs Monthly data plan for Internet 
connection
As negotiated by University 
Center for Telehealth and 
Telemedicine
$40.81 1 $40.81 $82.18 X
Mobile tablet warranty Monthly cost is $4.15, 
calculated from total $99 per 
device for 2-year warranty
$4.15 1 $4.15 X
Booklets for device training guide 
and intervention
Requiring paper, printing, and 
binding for
$19.21 1 $37.22 X
(1) Intervention $17.93 1
(2) Mobile tablet training 
guide booklet
$0.08 1
(3) Manila envelope
Delivery costs Delivery protective box Delivering mobile tablet 
device and booklets
$8.72 1 $8.72 $53.84 X
Shipping cost Ranging from $17.21–$25.83 
depending on delivery region
$22.56 2 $45.12 X
Personnel cost Interventionist 1 Health counselor $70/h 1 $70 $190 X
Interventionist 2 Psychiatric nurse specialist $70/h 1 $70 X
Technician Telehealth system coordinator $50/h 1 $50 X
Total cost $916.64
HIPAA, Health Insurance Portability and Accountability Act.
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